Γ

SynBioBeta Speaker

Clarice Aiello

Quantum Biology Inst

Chair of the Board

Clarice D. Aiello is a quantum engineer interested in how quantum physics informs biology. She is the co-founder of the Quantum Biology Ecosystem, which is bringing about the quantum biology industry by design. The Ecosystem's research arm, the Quantum Biology Institute, performs basic research underpinning the field in an open-science fashion. Clarice is the preeminent scientist in the field of quantum biology, having given more than 100 talks, incl. for NIH, NSF, NASA, MIT Lincoln Labs, Los Alamos Natl. Labs, and the European Commission. Born and raised in Brazil, Clarice has a Diplome d’Ingenieur in Physics from the Ecole Polytechnique in France and an M.Phil. in Physics from the University of Cambridge, Trinity College, in England; she received her Ph.D. from MIT in Electrical Engineering. She further held postdoctoral appointments in Bioengineering at Stanford, and in Chemistry at Berkeley. Clarice is writing the first-ever textbook on Quantum Biology.

Sessions Featuring

Clarice

This Year

Femtech

3:30 PM

-

4:15 PM

Human Health

Epigenetics and Stem Cells Reprogramming / Evidence Based Longevity

Aging is not a destiny. It is a program. And programs can be rewritten.Epigenetic clocks are now precise enough to measure biological age down to the tissue level. Stem cell engineering is restoring function in systems once thought irreversible. Longevity science — for the first time in its history — has the tools to match its ambitions.This chamber convenes the researchers doing the matching: scientists who have moved past the supplement stacks and the headlines, into the hard, exacting work of understanding what drives cellular aging — and what, with enough precision, can slow it, reverse it, or render it beside the point.

Femtech

3:30 PM

-

4:15 PM

Human Health

Epigenetics and Stem Cells Reprogramming / Evidence Based Longevity

Aging is not a destiny. It is a program. And programs can be rewritten.Epigenetic clocks are now precise enough to measure biological age down to the tissue level. Stem cell engineering is restoring function in systems once thought irreversible. Longevity science — for the first time in its history — has the tools to match its ambitions.This chamber convenes the researchers doing the matching: scientists who have moved past the supplement stacks and the headlines, into the hard, exacting work of understanding what drives cellular aging — and what, with enough precision, can slow it, reverse it, or render it beside the point.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include